GridAI Technologies (GRDX) Total Current Liabilities (2015 - 2025)
GridAI Technologies' (GRDX) quarterly Total Current Liabilities came in at $15.2 million in Q4 2025, down 44.97% YoY from $27.5 million in Q4 2024, and down 54.77% on a QoQ basis from $33.5 million in Q3 2025.
GridAI Technologies (GRDX) Total Current Liabilities (2015 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has 11 years of Total Current Liabilities data on file, last reported at $15.2 million in Q4 2025.
- Quarterly Total Current Liabilities fell 44.97% year-over-year to $15.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $15.2 million (down 44.97% YoY) and the FY2025 annual result came in at $15.2 million, down 44.97% from the prior year.
- Total Current Liabilities eased to $15.2 million in Q4 2025, from $33.5 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $33.5 million in Q3 2025 to a low of $71497.0 in Q3 2021.
- A 5-year average of $12.3 million and a median of $9.5 million in 2021 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2021 — Total Current Liabilities plunged 97.28% — and 2022, when it jumped 9262.85%.
- Tracing GRDX's Total Current Liabilities over 5 years: stood at $12.3 million in 2021, then tumbled by 79.81% to $2.5 million in 2022, then gained by 26.17% to $3.1 million in 2023, then soared by 779.14% to $27.5 million in 2024, then slumped by 44.97% to $15.2 million in 2025.
- The last three Total Current Liabilities figures came in at $15.2 million (Q4 2025), $33.5 million (Q3 2025), and $29.7 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 86.46 Bn | 78.47 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 65.62 Bn | 60.44 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 58.37 Bn | 53.24 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.43 Bn | 992.69 Mn | 1.51 Bn |
| 7 | BioNTech SE | 28.27 Bn | 9.87 Bn | 668.28 Mn | 2.49 Bn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 438.74 Mn |
| 9 | Royalty Pharma | 27.23 Bn | 26.40 Bn | - | 630.93 Mn |
| 10 | GridAI Technologies | 6.06 Mn | 6.06 Mn | - | 15.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15.16 Mn |
| Sep 30, 2025 | 33.52 Mn |
| Jun 30, 2025 | 29.68 Mn |
| Mar 31, 2025 | 28.74 Mn |
| Dec 31, 2024 | 27.55 Mn |
| Sep 30, 2024 | 15.69 Mn |
| Jun 30, 2024 | 15.38 Mn |
| Mar 31, 2024 | 6.17 Mn |
| Dec 31, 2023 | 3.13 Mn |
| Sep 30, 2023 | 2.48 Mn |
| Jun 30, 2023 | 3.26 Mn |
| Mar 31, 2023 | 2.62 Mn |
| Dec 31, 2022 | 2.48 Mn |
| Sep 30, 2022 | 6.69 Mn |
| Jun 30, 2022 | 17.28 Mn |
| Mar 31, 2022 | 14.22 Mn |
| Dec 31, 2021 | 12.30 Mn |
| Sep 30, 2021 | 71,497.00 |
| Jun 30, 2021 | 6.45 Mn |
| Mar 31, 2021 | 3.57 Mn |